Latest News about Biotech
Recent news which mentions Biotech
GSK's Asthma Drug Meets Main Goal In Phase 3 Study In Patients With Smoker's Lungs, Prepares Competition With Amgen/AstraZeneca's Drug
September 06, 2024
From Benzinga
No Brand, No Problem: California Company Powers Top Weed Brands Behind The Scenes Via White-Labeling
September 05, 2024
Tickers
NEWS
From Benzinga
Apple Watch Saves Life Of Pregnant Woman And Her Baby: 'That Information Is Like Gold'
September 05, 2024
From Benzinga
Goldman Sachs Shifts Stance On Novartis, Cites Lack Of Near-Term Catalysts
September 05, 2024
From Benzinga
Johnson & Johnson Raises Talc Settlement Offer to $9B, Moves Closer to Settlement Victory
September 05, 2024
From Benzinga
From Benzinga
From Benzinga
From Benzinga
BioMarin Restructures, Outlines Roadmap To $4B Revenues By 2027
September 05, 2024
From Benzinga
Eli Lilly's Once-Weekly Insulin Shows Non-Inferior Blood Sugar Reduction Vs Frequently Used Daily Insulins In Long Term Trials
September 05, 2024
From Benzinga
Five things: Suffolk Downs' first retailer, Orpheum lawsuit, pig kidneys and the birds people love to hate
September 05, 2024
From Business Journals
Ascendis Pharma Faces Challenges With Skytrofa And Yorvipath Pricing: Analysts Weigh In
September 04, 2024
From Benzinga
Court Orders Johnson & Johnson To Compensate Auris Health Shareholders $1B
September 04, 2024
From Benzinga
From Benzinga
Biogen's Higher Dose Spinraza Shows To Slow Neurodegeneration Faster In Infants With Rare Neuromuscular Disorder
September 04, 2024
From Benzinga
Biotech Stocks Are Perking Up. This ETF Is Responding
September 04, 2024
From ETF Trends
Rare Disease-Focused Ascendis Pharma Stock Falls On Underwhelming Q2 Earnings, Guidance Cut
September 04, 2024
From Benzinga
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.